Akèy › Dematit atopik (Ekzema) › Alabama › Birmingham
Etid klinik pou Dematit atopik (Ekzema) nan Birmingham, AL
9 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Ap rekriteEtid obsèvasyon
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006, Birmingham
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Ap rekriteFaz 2
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- Enveda Investigative Site, Birmingham
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Ap rekriteFaz 1Volontè an sante akeyi
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Ap rekriteFaz 3
- Cahaba Dermatology & Skin Health Center, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Ap rekriteFaz 3
- Leo Pharma Investigational site, Birmingham
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Ap rekriteFaz 3
- Cahaba Dermatology & Skin Health Center /ID# 263855, Birmingham
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Ap rekriteFaz 2
- Allervie Clinical Research, Birmingham
Etid Dematit atopik (Ekzema) nan lòt vil
- New York City, NY13 etid
- Washington, DC11 etid
- Los Angeles, CA11 etid
- San Diego, CA10 etid
- San Antonio, TX10 etid
- Miami, FL9 etid
- Troy, MI8 etid
- Huntington Beach, CA8 etid
- Dallas, TX8 etid
- Sacramento, CA8 etid
- Tampa, FL7 etid
- Indianapolis, IN7 etid
Lòt etid nan Birmingham
- Kansè (tout kalite)30 etid
- Kansè nan tete24 etid
- Obèsite23 etid
- Kansè ovè23 etid
- Kansè Poumon ki pa ti selil22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip18 etid
- BPCO17 etid
- Maladi kadyovaskilè17 etid
- Sipwa16 etid
- Kansè Endomèt16 etid
- Dyabèt Tip 216 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.